Skip to main content
. 2021 Jan 5;2(1):22–32. doi: 10.1302/2633-1462.21.BJO-2020-0150.R1

Table VI.

Phase II incidence of predictor variables.

Factor Total (n = 1,226) Baseline and 12 month SMFA Dysfunction Index (n = 687)
Reoperations in response to infection, n (%)
Late* 12 (1.0) 7 (1.0)
Early 39 (3.2) 16 (2.3)
None 1,175 (95.8) 664 (96.7)
Fasciotomy, n (%)
Late* 0 (0.0) 0 (0.0)
Early 22 (1.8) 16 (2.3)
None 1204 (98.2) 671 (97.7)
Bone graft, n (%)
Late* 6 (0.5) 4 (0.6)
Early 11 (0.9) 5 (0.7)
None 1,209 (98.6) 678 (98.7)
Implant exchange, n (%)
Late* 15 (1.2) 7 (1.0)
Early 25 (2.0) 10 (1.5)
None 1,186 (96.7) 670 (97.5)
Bone graft and/or implant exchange, n (%)
Late* 17 (1.4) 8 (1.2)
Early 31 (2.5) 11 (1.6)
None 1,178 (96.1) 668 (97.2)
Nonoperatively treated infection, n (%)
Late* 0 (0.0) 0 (0.0)
Early 19 (1.5) 9 (1.3)
None 1,207 (98.5) 678 (98.7)
Dynamization, n (%)
Late* 18 (1.5) 11 (1.6)
Early 99 (8.1) 64 (9.3)
None 1,109 (90.5) 612 (89.1)
*

Early is defined as prior to eight months from initial surgery and late is defined as eight months up to one year.

SMFA, Short Musculoskeletal Functional Assessment